
Masoud H. Noori
Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2214, 2856, 2616 |
| Total Applications | 3955 |
| Issued Applications | 3448 |
| Pending Applications | 170 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17755726
[patent_doc_number] => 11396007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Catalyst supports--composition and process of manufacture
[patent_app_type] => utility
[patent_app_number] => 17/405201
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9596
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405201 | Catalyst supports--composition and process of manufacture | Aug 17, 2021 | Issued |
Array
(
[id] => 18739480
[patent_doc_number] => 20230348410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => PURIFICATION OF 2,5-FURANDICARBOXYLIC ACID, DIMETHYL ESTER AND OTHER ESTERIFIED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/041394
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041394
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041394 | PURIFICATION OF 2,5-FURANDICARBOXYLIC ACID, DIMETHYL ESTER AND OTHER ESTERIFIED PRODUCTS | Jul 28, 2021 | Pending |
Array
(
[id] => 17356754
[patent_doc_number] => 20220017550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/387864
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 562
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387864 | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Jul 27, 2021 | Issued |
Array
(
[id] => 18748317
[patent_doc_number] => 11807613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Integrated methods for chemical synthesis
[patent_app_type] => utility
[patent_app_number] => 17/386627
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 24167
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386627 | Integrated methods for chemical synthesis | Jul 27, 2021 | Issued |
Array
(
[id] => 18764018
[patent_doc_number] => 11814404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Inhibitors of complement factors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/379334
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123439
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 386
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379334 | Inhibitors of complement factors and uses thereof | Jul 18, 2021 | Issued |
Array
(
[id] => 18146194
[patent_doc_number] => 20230020051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHOD AND INTEGRATED PROCESS FOR THE CARBOXYLATION OF FURAN DERIVED CARBOXYLIC ACIDS TO 2,5-FURANDICARBOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/377851
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377851 | Method and integrated process for the carboxylation of furan derived carboxylic acids to 2,5-furandicarboxylic acid | Jul 15, 2021 | Issued |
Array
(
[id] => 18420064
[patent_doc_number] => 20230174525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047
[patent_app_type] => utility
[patent_app_number] => 18/015828
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015828
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015828 | POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047 | Jul 11, 2021 | Pending |
Array
(
[id] => 18535973
[patent_doc_number] => 20230241060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => GLUCOCORTICOID-SPARING AGENT
[patent_app_type] => utility
[patent_app_number] => 18/004806
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004806
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004806 | GLUCOCORTICOID-SPARING AGENT | Jul 7, 2021 | Pending |
Array
(
[id] => 18753846
[patent_doc_number] => 20230357148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => INDOLE DERIVATIVE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/013688
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013688
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013688 | Indole derivative and application thereof | Jul 1, 2021 | Issued |
Array
(
[id] => 17185194
[patent_doc_number] => 20210332079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/365208
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365208 | SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME | Jun 30, 2021 | Abandoned |
Array
(
[id] => 18496096
[patent_doc_number] => 20230218639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION
[patent_app_type] => utility
[patent_app_number] => 18/008560
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008560 | USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION | Jun 24, 2021 | Pending |
Array
(
[id] => 18647779
[patent_doc_number] => 20230293551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/008582
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008582
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008582 | USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE CONDITIONS | Jun 24, 2021 | Abandoned |
Array
(
[id] => 18626619
[patent_doc_number] => 20230285416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES
[patent_app_type] => utility
[patent_app_number] => 18/008588
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008588 | USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES | Jun 24, 2021 | Pending |
Array
(
[id] => 17609762
[patent_doc_number] => 20220152041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/353717
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353717 | Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies | Jun 20, 2021 | Issued |
Array
(
[id] => 18665216
[patent_doc_number] => 11772082
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-03
[patent_title] => Catalyst supports--composition and process of manufacture
[patent_app_type] => utility
[patent_app_number] => 17/347620
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9589
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347620 | Catalyst supports--composition and process of manufacture | Jun 14, 2021 | Issued |
Array
(
[id] => 17428279
[patent_doc_number] => 20220055987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITIONS OF TROFINETIDE
[patent_app_type] => utility
[patent_app_number] => 17/347135
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347135 | Compositions of trofinetide | Jun 13, 2021 | Issued |
Array
(
[id] => 18497296
[patent_doc_number] => 20230219910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/000908
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -104
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000908 | CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF | Jun 6, 2021 | Pending |
Array
(
[id] => 18610798
[patent_doc_number] => 20230277528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 18/009050
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009050 | COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION | Jun 2, 2021 | Pending |
Array
(
[id] => 17228543
[patent_doc_number] => 20210355099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => HIGHLY EFFICIENT SYNTHESIS OF Z-MACROCYCLES USING STEREORETENTIVE, RUTHENIUM-BASED METATHESIS CATALYSTS
[patent_app_type] => utility
[patent_app_number] => 17/336756
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336756 | Highly efficient synthesis of Z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts | Jun 1, 2021 | Issued |
Array
(
[id] => 17297773
[patent_doc_number] => 20210393612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => POLYMORPHIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/334094
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334094 | Polymorphic compounds and uses thereof | May 27, 2021 | Issued |